Unions: Trade pact provisions would push drug prices higher

12/19/2013 | Hill, The

Policies being pushed by the U.S. for inclusion in the Trans-Pacific Partnership and the Transatlantic Trade and Investment Partnership would raise the costs of drugs and limit governments' choices on health care, according to unions from the European Union and the U.S. "It is imperative that these trade and investment agreements result in increased savings for patients and national budgets instead of further enriching a few pharmaceutical and medical corporations," they wrote in a letter to EU Trade Commissioner Karel De Gucht and U.S. Trade Representative Michael Froman.

View Full Article in:

Hill, The

Published in Brief: